EP Patent

EP2636404B1 — Methods of Treating Non-Alcoholic Steatohepatitis (Nash) Using Cysteamine Products

Assigned to University of California · Expires 2019-03-20 · 7y expired

What this patent protects

Patent listed against cysteamine-bitartrate.

Drugs covered by this patent

cysteamine-bitartrate (CYSTEAMINE BITARTRATE)

Patent Metadata

Patent number: EP2636404B1
Jurisdiction: EP
Classification: —
Expires: 2019-03-20
Drug substance claim: No
Drug product claim: No
Assignee: University of California
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.